Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

statistics

  • You have access
    Cost-effectiveness of 18F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy
    Jurij Rosen, Garry Ceccon, Elena Katharina Bauer, Jan Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schaefer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon Rudolf Fink, Karl-Josef Langen and Norbert Galldiks
    Journal of Nuclear Medicine April 14, 2022, jnumed.122.263790; DOI: https://doi.org/10.2967/jnumed.122.263790
  • You have access
    Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development
    Tyler J. Bradshaw, Ronald Boellaard, Joyita Dutta, Abhinav K. Jha, Paul Jacobs, Quanzheng Li, Chi Liu, Arkadiusz Sitek, Babak Saboury, Peter J.H. Scott, Piotr J. Slomka, John J. Sunderland, Richard L. Wahl, Fereshteh Yousefirizi, Sven Zuehlsdorff, Arman Rahmim and Irène Buvat
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 500-510; DOI: https://doi.org/10.2967/jnumed.121.262567
  • You have access
    Statistical Considerations in the Evaluation of Continuous Biomarkers
    Mei-Yin C. Polley and James J. Dignam
    Journal of Nuclear Medicine May 10, 2021, 62 (5) 605-611; DOI: https://doi.org/10.2967/jnumed.120.251520
  • You have access
    Prognostic Value of Total Lesion Glycolysis by 18F-FDG PET/CT in Surgically Resected Stage IA Non–Small Cell Lung Cancer
    Seong Yong Park, Arthur Cho, Woo Sik Yu, Chang Young Lee, Jin Gu Lee, Dae Joon Kim and Kyung Young Chung
    Journal of Nuclear Medicine January 1, 2015, 56 (1) 45-49; DOI: https://doi.org/10.2967/jnumed.114.147561
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire